Skip to Main Content

News

Attention Members and Providers: MHS wants you to know about a recent drug recall.

Date: 09/05/18

On August 27, 2018, the U.S. Food and Drug Administration (FDA) announced that Accord Healthcare, Inc. was voluntarily recalling one lot of hydrochlorothiazide 12.5 mg tablets to the consumer level.

The FDA press release states the following:

A 100 count bottle of Hydrochlorothiazide Tablets USP 12.5 mg has been found to contain 100 Spironolactone Tablets USP 25 mg. Since the individual lot, PW05264, of the product is involved in a potential mix-up of labeling, Accord is recalling this individual lot from the market. Based on findings of both preliminary and interim investigations carried out at the manufacturing site, Accord believes that no other lots of Hydrochlorothiazide Tablets are involved in this mix-up. Accord became aware of this finding through a product complaint reported from a pharmacy. Accord is notifying its Wholesalers, Distributors and Retailers by letter and is arranging for return of all recalled products. Wholesalers, Distributors and Retailers that have the product being recalled should discontinue distribution of the product and notify consumers. Consumers that have the product should return the product to the pharmacy.

Consumers/Pharmacies with questions regarding this recall can contact Accord Healthcare, Inc. by phone at 1.855.869.1081, fax: 1.817.868.5362 or e-mail at rxrecalls@inmar.com Monday to Friday during business hours 8 am to 5 pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.